, RelA Myc Tag His Tag Mixed

E. Alcamo, N. Hacohen, L. Schulte, P. Rennert, R. Hynes et al., Requirement for the NF-??B Family Member RelA in the Development of Secondary Lymphoid Organs, The Journal of Experimental Medicine, vol.269, issue.2, pp.233-277, 2002.
DOI : 10.1073/pnas.93.20.11019

S. Alonso, P. Ortiz, M. Pollan, B. Prez-gomez, L. Sanchez et al., Progression in Cutaneous Malignant Melanoma Is Associated with Distinct Expression Profiles, The American Journal of Pathology, vol.164, issue.1, pp.193-203, 2004.
DOI : 10.1016/S0002-9440(10)63110-0

K. Amiri and A. Richmond, Role of nuclear factor-?? B in melanoma, Cancer and Metastasis Reviews, vol.278, issue.2, pp.301-314, 2005.
DOI : 10.1128/MCB.18.9.5157

A. Ashkenazi, Directing cancer cells to self-destruct with pro-apoptotic receptor agonists, Nature Reviews Drug Discovery, vol.14, issue.12, pp.1001-1013, 2008.
DOI : 10.1128/MCB.20.3.929-935.2000

S. J. Baker and E. P. Reddy, Targeted Inhibition of Kinases in Cancer Therapy, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, vol.26, issue.part 1, pp.573-586, 2010.
DOI : 10.4049/jimmunol.173.7.4699

C. Balch and N. Cascinelli, The new melanoma staging system, Tumori, vol.87, issue.4, pp.64-72, 2001.

A. Baldwin and . Jr, THE NF-??B AND I??B PROTEINS: New Discoveries and Insights, Annual Review of Immunology, vol.14, issue.1, pp.649-83, 1996.
DOI : 10.1146/annurev.immunol.14.1.649

J. Bash, W. Zong, and C. Gélinas, c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition., Molecular and Cellular Biology, vol.17, issue.11, pp.6526-6562, 1997.
DOI : 10.1128/MCB.17.11.6526

J. Bauer and C. Garbe, Acquired Melanocytic Nevi as Risk Factor for Melanoma Development. A Comprehensive Review of Epidemiological Data, Pigment Cell Research, vol.14, issue.Suppl. 2, pp.297-306, 2003.
DOI : 10.1159/000056358

B. Baumgartner, M. Weber, M. Quirling, C. Fischer, S. Page et al., Increased I??B kinase activity is associated with activated NF-??B in acute myeloid blasts, Leukemia, vol.349, issue.10, pp.2062-2071, 2002.
DOI : 10.1016/S0140-6736(96)08086-5

A. Bennour, A. Saad, and H. Sennana, Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays, Critical Reviews in Oncology/Hematology, vol.97, pp.263-74, 2016.
DOI : 10.1016/j.critrevonc.2015.08.020

R. Bitencourt, I. Zalcberg, D. Louro, and I. , Imatinib resistance, Revista Brasileira de Hematologia e Hemoterapia, vol.33, issue.6, pp.470-475, 2011.
DOI : 10.5581/1516-8484.20110124

J. Bliss, D. Ford, A. Swerdlow, B. Armstrong, M. Cristofolini et al., Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case-control studies, International Journal of Cancer, vol.131, issue.4, pp.367-76, 1995.
DOI : 10.1038/bjc.1986.10

M. Blonska, P. Shambharkar, M. Kobayashi, D. Zhang, H. Sakurai et al., TAK1 Is Recruited to the Tumor Necrosis Factor-?? (TNF-??) Receptor 1 Complex in a Receptor-interacting Protein (RIP)-dependent Manner and Cooperates with MEKK3 Leading to NF-??B Activation, Journal of Biological Chemistry, vol.11, issue.52, pp.43056-63, 2005.
DOI : 10.1128/MCB.25.14.5955-5964.2005

A. Boiko, O. Razorenova, M. Van-de-rijn, S. Swetter, D. Johnson et al., Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, Nature, vol.453, issue.7302, pp.133-140, 2010.
DOI : 10.1177/36.4.2831267

M. Bond, R. Fabunmi, A. Baker, and A. Newby, Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-??B, FEBS Letters, vol.296, issue.1, pp.29-34, 1998.
DOI : 10.1016/0014-5793(92)80378-T

V. Bours, E. Dejardin, . Goujon-letawe-?-f, M. Merville, and V. Castronovo, The NF-??B transcription factor and cancer: high expression of NF-??B- and I??B-related proteins in tumor cell lines, Biochemical Pharmacology, vol.47, issue.1, pp.145-154, 1994.
DOI : 10.1016/0006-2952(94)90448-0

G. Bren, N. Solan, H. Miyoshi, K. Pennington, L. Pobst et al., Transcription of the RelB gene is regulated by NF-??B, Oncogene, vol.20, issue.53, pp.7722-7755, 2001.
DOI : 10.1016/0092-8674(95)90416-6

V. Bruttel and J. Wischhusen, Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?, Frontiers in Immunology, vol.61, issue.3, p.360, 2014.
DOI : 10.1007/s00262-011-1106-3

K. Campbell and N. Perkins, Post-translational modification of RelA(p65) NF-??B, Biochemical Society Transactions, vol.32, issue.6, pp.1087-1096, 2004.
DOI : 10.1042/BST0321087

G. Carrà, D. Torti, S. Crivellaro, C. Panuzzo, R. Taulli et al., The BCR-ABL/NF-?B signal transduction network: a long lasting relationship in Philadelphia positive Leukemias, Oncotarget, vol.7, issue.40, pp.66287-66298, 2016.

S. Catz and J. Johnson, Transcriptional regulation of bcl-2 by nuclear factor ??B and its significance in prostate cancer, Oncogene, vol.20, issue.50, pp.7342-51, 2001.
DOI : 10.1016/S0092-8674(00)80501-2

J. Chambard, R. Lefloch, J. Pouysségur, and P. Lenormand, ERK implication in cell cycle regulation, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1773, issue.8, pp.1299-310, 2007.
DOI : 10.1016/j.bbamcr.2006.11.010
URL : https://hal.archives-ouvertes.fr/hal-00320768

M. Chaturvedi, B. Sung, V. Yadav, R. Kannappan, and B. Aggarwal, NF-??B addiction and its role in cancer: ???one size does not fit all???, Oncogene, vol.177, issue.14, pp.1615-1645, 2011.
DOI : 10.4049/jimmunol.177.1.665

J. Chen, C. Jiang, L. Jin, and X. Zhang, Regulation of PD-L1: a novel role of pro-survival signalling in cancer, Annals of Oncology, vol.117, issue.e954463, pp.409-425, 2016.
DOI : 10.1158/1078-0432.CCR-14-2339

J. Chen, S. Liu, . Fei, . Hb, and W. Gong, Preliminary research on the p53 gene rearrangements in the evolution of chronic myelogenous leukemia to blast crisis, J Tongii Med Univ, vol.14, issue.4, pp.204-212, 1994.

L. Chen and W. Greene, Regulation of distinct biological activities of the NF-?B transcription factor complex by acetylation, Journal of Molecular Medicine, vol.81, issue.9, pp.549-57, 2003.
DOI : 10.1007/s00109-003-0469-0

L. Chen, Y. Mu, and W. Greene, Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB, The EMBO Journal, vol.21, issue.23, pp.6539-6587, 2002.
DOI : 10.1093/emboj/cdf660

Y. Cho, S. Challa, D. Moquin, R. Genga, T. Ray et al., Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation, Cell, vol.137, issue.6, pp.1112-1135, 2009.
DOI : 10.1016/j.cell.2009.05.037
URL : https://doi.org/10.1016/j.cell.2009.05.037

R. Chopra, Q. Pu, and A. Elefanty, Biology of BCR-ABL. Blod, vol.13, issue.4, pp.211-240, 1999.

J. Christian, J. Vier, S. Paschen, and G. Häcker, Cleavage of the NF-??B Family Protein p65/RelA by the Chlamydial Protease-like Activity Factor (CPAF) Impairs Proinflammatory Signaling in Cells Infected with Chlamydiae, Journal of Biological Chemistry, vol.173, issue.53, pp.41320-41327, 2010.
DOI : 10.1126/science.1096330

D. Cilloni and G. Saglio, Molecular Pathways: BCR-ABL, Clinical Cancer Research, vol.18, issue.4, pp.930-937, 2012.
DOI : 10.1158/1078-0432.CCR-10-1613

A. Clark and D. Vignjevic, Modes of cancer cell invasion and the role of the microenvironment, Current Opinion in Cell Biology, vol.36, pp.13-22, 2015.
DOI : 10.1016/j.ceb.2015.06.004

W. Clark, . Jr, D. Elder, D. Guerry, L. Braitman et al., Model Predicting Survival in Stage I Melanoma Based on Tumor Progression, JNCI Journal of the National Cancer Institute, vol.81, issue.24, pp.1893-904, 1989.
DOI : 10.1093/jnci/81.24.1893

W. Clark, Tumour progression and the nature of cancer, British Journal of Cancer, vol.64, issue.4, pp.631-675, 1991.
DOI : 10.1038/bjc.1991.375

M. Coiras, M. Lopez-huertas, E. Mateos, and J. Alcami, Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes, Retrovirology, vol.5, issue.109, 2008.

P. Coppo, S. Flamant, V. De-mas, P. Jarrier, M. Guiller et al., BCR-ABL activates STAT3 via JAK and MEK pathways in human cells, British Journal of Haematology, vol.267, issue.2, pp.171-180, 2006.
DOI : 10.1038/sj.onc.1205152

G. Courtois and T. Gilmore, Mutations in the NF-??B signaling pathway: implications for human disease, Oncogene, vol.25, issue.51, pp.6831-6874, 2006.
DOI : 10.1002/humu.9231

M. Covert, T. Leung, J. Gaston, and D. Baltimore, Achieving Stability of Lipopolysaccharide-Induced NF-??B Activation, Science, vol.309, issue.5742, pp.1854-1861, 2005.
DOI : 10.1126/science.1112304

C. Craddock, N. Jilani, S. Siddique, C. Yap, J. Khan et al., Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial, Biology of Blood and Marrow Transplantation, vol.22, issue.2, pp.385-390, 2016.
DOI : 10.1016/j.bbmt.2015.09.004

M. Damaghi, J. Wojtkowiak, and R. Gillies, pH sensing and regulation in cancer, Frontiers in Physiology, vol.4, issue.370, 2013.
DOI : 10.3389/fphys.2013.00370

R. Davey, A. Van-der-westhuizen, and N. Bowden, Metastatic melanoma treatment: Combining old and new therapies, Critical Reviews in Oncology/Hematology, vol.98, pp.242-53, 2016.
DOI : 10.1016/j.critrevonc.2015.11.011

W. Declercq, T. Vanden-berghe, and P. Vandenabeele, RIP Kinases at the Crossroads of Cell Death and Survival, Cell, vol.138, issue.2, pp.229-261, 2009.
DOI : 10.1016/j.cell.2009.07.006

E. Dejardin, G. Bonizzi, A. Bellahcène, V. Castronovo, M. Merville et al., Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells, Oncogene, vol.11, issue.9, pp.1835-1876, 1995.

P. Dempsey, S. Doyle, J. He, and G. Cheng, The signaling adaptors and pathways activated by TNF superfamily, Cytokine & Growth Factor Reviews, vol.14, issue.3-4, pp.193-209, 2003.
DOI : 10.1016/S1359-6101(03)00021-2

L. Deng, Y. Lin-lee, F. Claret, and M. Kuo, Expression through Generating Reactive Oxygen Species That Activate NF-??B Pathway, Journal of Biological Chemistry, vol.106, issue.1, pp.413-433, 2001.
DOI : 10.1289/ehp.98106s1289

C. Denkert, M. Köbel, S. Berger, A. Siegert, A. Leclere et al., Expression of cyclooxygenase 2 in human malignant melanoma, Cancer Res, vol.61, issue.1, pp.303-311, 2001.

Q. Deveraux, N. Roy, H. Stennicke, T. Van-arsdale, Q. Zhou et al., IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases, The EMBO Journal, vol.17, issue.8, pp.2215-2238, 1998.
DOI : 10.1093/emboj/17.8.2215
URL : http://emboj.embopress.org/content/embojnl/17/8/2215.full.pdf

P. Dhawan and A. Richmond, A Novel NF-??B-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-??B Activity in Melanoma Cells, Journal of Biological Chemistry, vol.160, issue.10, pp.7920-7928, 2002.
DOI : 10.1074/jbc.272.24.15366
URL : http://www.jbc.org/content/277/10/7920.full.pdf

D. Dingli, A. Traulsen, T. Lenaerts, and J. Pacheco, Evolutionary Dynamics of Chronic Myeloid Leukemia, Genes & Cancer, vol.1, issue.4, pp.309-324, 2010.
DOI : 10.1177/1947601910371122

Y. Dondelinger, S. Jouan-lanhouet, T. Divert, E. Theatre, J. Bertin et al., NF-??B-Independent Role of IKK??/IKK?? in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling, Molecular Cell, vol.60, issue.1, pp.63-76, 2015.
DOI : 10.1016/j.molcel.2015.07.032

D. Duffey, Z. Chen, G. Dong, F. Ondrey, J. Wolf et al., Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo, Cancer Research, vol.59, issue.14, pp.3468-74, 1999.

H. Dyson and E. Komives, Role of disorder in I??B-NF??B interaction, IUBMB Life, vol.3, issue.6, pp.499-505, 2012.
DOI : 10.1038/msb4100148

C. Elza, . De-bruin, and J. Medema, Apoptosis and non-apoptotic deaths in cancer development and treatment response, Cancer Treatment Reviews, vol.34, pp.737-749, 2008.

S. Feng, Y. Yang, Y. Mei, L. Ma, D. Zhu et al., Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain, Cellular Signalling, vol.19, issue.10, pp.2056-67, 2007.
DOI : 10.1016/j.cellsig.2007.05.016

M. Foletto and S. Haas, Cutaneous melanoma: new advances in treatment, Anais Brasileiros de Dermatologia, vol.29, issue.2, pp.301-311, 2014.
DOI : 10.1200/JCO.2010.33.9275
URL : http://www.scielo.br/pdf/abd/v89n2/0365-0596-abd-89-02-0301.pdf

C. Fozza, G. Corda, F. Barraqueddu, P. Virdis, S. Contini et al., Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia, Leukemia Research, vol.39, issue.9, pp.957-63, 2015.
DOI : 10.1016/j.leukres.2015.06.007

A. Gang, T. Frosig, M. Brimnes, R. Lyngaa, M. Treppendahl et al., Hadrup, SR. 5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies, Blood Cancer J, vol.28, issue.4, p.197, 2014.

C. Garcia-echeverria and W. Sellers, Drug discovery approaches targeting the PI3K/Akt pathway in cancer, Oncogene, vol.64, issue.41, pp.5511-5537, 2008.
DOI : 10.1128/MCB.16.4.1722
URL : http://www.nature.com/onc/journal/v27/n41/pdf/onc2008246a.pdf

C. Gasparini, C. Celeghini, L. Monasta, and G. Zauli, NF-??B pathways in hematological malignancies, Cellular and Molecular Life Sciences, vol.202, issue.3, pp.2083-102, 2014.
DOI : 10.1002/jcp.20202

S. Gerondakis, R. Grumont, R. Gugasyan, L. Wong, I. Isomura et al., Unravelling the complexities of the NF-??B signalling pathway using mouse knockout and transgenic models, Oncogene, vol.25, issue.51, pp.6781-99, 2006.
DOI : 10.4049/jimmunol.170.4.1995

P. Geserick, J. Wang, R. Schilling, S. Horn, P. Harris et al., Absence of RIPK3 predicts necroptosis resistance in malignant melanoma, Cell Death & Disease, vol.961, issue.9, p.1884, 2015.
DOI : 10.1007/978-1-62703-227-8_12

G. Ghosh, V. Wang, D. Huang, and A. Fusco, NF-??B regulation: lessons from structures, Immunological Reviews, vol.278, issue.1, pp.36-58, 2012.
DOI : 10.1074/jbc.M304278200
URL : http://europepmc.org/articles/pmc4543363?pdf=render

S. Ghosh and J. Dass, Study of pathway cross-talk interactions with NF-??B leading to its activation via ubiquitination or phosphorylation: A brief review, Gene, vol.584, issue.1, pp.97-109, 2016.
DOI : 10.1016/j.gene.2016.03.008

B. Gilchrest, M. Eller, A. Geller, and M. Yaar, The Pathogenesis of Melanoma Induced by Ultraviolet Radiation, New England Journal of Medicine, vol.340, issue.17, pp.1341-1349, 1999.
DOI : 10.1056/NEJM199904293401707

T. Gilmore, M. Koedood, K. Piffat, and D. White, NF-kappaB/IkappaB proteins and cancer, Oncogene, vol.13, issue.7, pp.1367-78, 1996.

J. Goldman, Chronic Myeloid Leukemia: A Historical Perspective, Seminars in Hematology, vol.47, issue.4, pp.302-313, 2010.
DOI : 10.1053/j.seminhematol.2010.07.001

. R. Gonon-demoulian, J. Goldman, and F. Nicolini, History of chronic myeloid leukemia: A paradigm in the treatment of cancer, Bulletin du cancer, vol.101, issue.1, pp.56-67, 2014.

F. Gonzalvez and A. Ashkenazi, New insights into apoptosis signaling by Apo2L/TRAIL, Oncogene, vol.173, issue.34, pp.4752-65, 2010.
DOI : 10.4049/jimmunol.173.9.5652

A. Gorbatenko, C. Olesen, E. Boedtkjer, and S. Pedersen, Regulation and roles of bicarbonate transporters in cancer, Frontiers in Physiology, vol.6, p.130, 2014.
DOI : 10.1038/nmeth0409-239

A. Goulet, J. Einsphar, D. Alberts, A. Beas, C. Burk et al., Analysis of Cyclooxygenase 2 (COX-2) Expression During Malignant Melanoma Progression, Cancer Biology & Therapy, vol.2, issue.6, pp.713-721, 2003.
DOI : 10.4161/cbt.2.6.627

K. Gowrishankar, D. Gunatilake, S. Gallagher, J. Tiffen, H. Rizos et al., Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-??B, PLOS ONE, vol.21, issue.1, p.123410, 2015.
DOI : 10.1371/journal.pone.0123410.s003

D. Green and F. Lambi, Cell Death Signaling. Cold Spring Harb Perspect Biol, vol.7, issue.12, 2015.

D. Grossman, J. Mcniff, F. Li, . Altieri, and . Dc, Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human Melanoma, Journal of Investigative Dermatology, vol.113, issue.6, pp.1076-81, 1999.
DOI : 10.1046/j.1523-1747.1999.00776.x

Y. Gu, T. Chen, Z. Meng, Y. Gan, X. Xu et al., CaMKII ??, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine, Blood, vol.29, issue.6, pp.4829-4868, 2012.
DOI : 10.1016/j.freeradbiomed.2009.06.022

D. Guertin and D. Sabatini, Defining the Role of mTOR in Cancer, Cancer Cell, vol.12, issue.1, pp.9-22, 2007.
DOI : 10.1016/j.ccr.2007.05.008

S. Gupta, N. Takebe, and P. Lorusso, Review: Targeting the Hedgehog pathway in cancer, Therapeutic Advances in Medical Oncology, vol.14, issue.4, pp.237-50, 2010.
DOI : 10.1038/nature07737

D. Guttridge, C. Albanese, J. Reuther, R. Pestell, and . Baldwin, NF-??B Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1, Molecular and Cellular Biology, vol.19, issue.8, pp.5785-99, 1999.
DOI : 10.1128/MCB.19.8.5785

M. Guzman, S. Neering, D. Upchurch, B. Grimes, D. Howard et al., Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells, Blood, vol.98, issue.8, pp.2301-2308, 2001.
DOI : 10.1182/blood.V98.8.2301

H. Häcker and M. Karin, Regulation and Function of IKK and IKK-Related Kinases, Science's STKE, vol.2006, issue.357, p.13, 2006.
DOI : 10.1126/stke.3572006re13

M. Hamdane, M. David-cordonnier, and J. D-'halluin, Activation of p65 NF-??B protein by p210BCR?????????ABL in a myeloid cell line (P210BCR?????????ABL activates p65 NF-??B), Oncogene, vol.15, issue.19, pp.2267-75, 1997.
DOI : 10.1038/sj.onc.1201411

D. Hanahan and R. A. Weinberg, The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000.
DOI : 10.1016/S0092-8674(00)81683-9

S. Harguindey, G. Orive, J. Pedraz, A. Paradiso, and S. Reshkin, The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin???one single nature, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1756, issue.1, pp.1-24, 2005.
DOI : 10.1016/j.bbcan.2005.06.004

S. He, L. Wang, L. Miao, T. Wang, F. Du et al., Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-??, Cell, vol.137, issue.6, pp.1100-1111, 2009.
DOI : 10.1016/j.cell.2009.05.021

A. Heerema-mckenney and D. Arber, Acute Myeloid Leukemia, Hematology/Oncology Clinics of North America, vol.23, issue.4, pp.633-54, 2009.
DOI : 10.1016/j.hoc.2009.04.003

S. Hirai, T. Kageshita, T. Kimura, M. Tsujisaki, K. Imai et al., Serum levels of slCAM-1 and 5-S-cysteinyldopa as markers of melanoma progression, Melanoma Research, vol.7, issue.1, pp.58-62, 1997.
DOI : 10.1097/00008390-199702000-00009

J. Hitomi, D. Christofferson, A. Ng, J. Yao, A. Degterev et al., Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway, Cell, vol.135, issue.7, pp.1311-1334, 2008.
DOI : 10.1016/j.cell.2008.10.044

M. Horita, E. Andreu, A. Benito, C. Arbona, C. Sanz et al., The Journal of Experimental Medicine, vol.159, issue.6, pp.977-84, 2000.
DOI : 10.1038/sj.onc.1202065

H. Hsu, J. Huang, H. Shu, V. Baichwal, and D. Goeddel, TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling Complex, Immunity, vol.4, issue.4, pp.387-96, 1996.
DOI : 10.1016/S1074-7613(00)80252-6

B. Huang, X. Yang, A. Lamb, and L. Chen, Posttranslational modifications of NF-??B: Another layer of regulation for NF-??B signaling pathway, Cellular Signalling, vol.22, issue.9, pp.1282-90, 2010.
DOI : 10.1016/j.cellsig.2010.03.017

D. Huang, T. Huxford, Y. Chen, and G. Ghosh, The role of DNA in the mechanism of NF??B dimer formation: crystal structures of the dimerization domains of the p50 and p65 subunits, Structure, vol.5, issue.11, pp.1427-1463, 1997.
DOI : 10.1016/S0969-2126(97)00293-1

D. Huang, D. Vu, and G. Ghosh, NF-??B RelB Forms an Intertwined Homodimer, Structure, vol.13, issue.9, pp.1365-73, 2005.
DOI : 10.1016/j.str.2005.06.018

S. Huang, Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical Implications, Clinical Cancer Research, vol.13, issue.5, pp.1362-1368, 2007.
DOI : 10.1158/1078-0432.CCR-06-2313

S. Hu-lieskovan, L. Robert, H. Moreno, B. Ribas, and A. , -Mutant Melanoma: Promise and Challenges, Journal of Clinical Oncology, vol.32, issue.21, pp.2248-54, 2014.
DOI : 10.1200/JCO.2013.52.1377

E. Hurst, J. Harbour, and L. Cornelius, Ocular Melanoma, Archives of Dermatology, vol.139, issue.8, pp.1067-73, 2003.
DOI : 10.1001/archderm.139.8.1067

K. Ilieva, I. Correa, D. Josephs, P. Karagiannis, I. Egbuniwe et al., Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to Melanoma, Molecular Cancer Therapeutics, vol.13, issue.12, pp.2769-83, 2014.
DOI : 10.1158/1535-7163.MCT-14-0290

V. Imbert and J. Peyton, NF-??B in Hematological Malignancies, Biomedicines, vol.9, issue.4, p.27, 2017.
DOI : 10.1016/j.molmed.2015.12.004

N. Ishimaru, H. Kishimoto, Y. Hayashi, and J. Sprent, Regulation of naive T cell function by the NF-??B2 pathway, Nature Immunology, vol.163, issue.7, pp.763-72, 2006.
DOI : 10.1016/S0002-9440(10)63505-5

H. Ishinaga, H. Jono, J. Lim, S. Kweon, H. Xu et al., TGF-?? induces p65 acetylation to enhance bacteria-induced NF-??B activation, The EMBO Journal, vol.1, issue.4, pp.1150-62, 2007.
DOI : 10.4049/jimmunol.173.2.962

V. Ivanov, O. Fodstad, and Z. Ronai, Expression of ring finger-deleted TRAF2 sensitizes metastatic melanoma cells to apoptosis via up-regulation of p38, TNF?? and suppression of NF-??B activities, Oncogene, vol.20, issue.18, pp.2243-53, 2001.
DOI : 10.1016/S0092-8674(00)80406-7

M. Jafri, S. Ansari, M. Alqahtani, and J. Shay, Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies, Genome Medicine, vol.15, issue.1, 2016.
DOI : 10.1016/S1470-2045(14)70236-0

M. Jamaluddin, S. Wang, I. Boldogh, B. Tian, and A. Brasier, TNF-??-induced NF-??B/RelA Ser276 phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway, Cellular Signalling, vol.19, issue.7, pp.1419-1452, 2007.
DOI : 10.1016/j.cellsig.2007.01.020

J. Fernández, D. Lamkanfi, and M. , Abstract, Biological Chemistry, vol.396, issue.3, pp.193-203, 2015.
DOI : 10.1515/hsz-2014-0253

S. Joha, Mécanismes de résistance aux inhibiteurs de tyrosine kinase sur le modèle de leucémie myéloïde chronique, 2009.

J. Johnson, B. Stade, B. Holzmann, W. Schwäble, and G. Riethmüller, De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis., Proceedings of the National Academy of Sciences, vol.86, issue.2, pp.641-645, 1989.
DOI : 10.1073/pnas.86.2.641

P. Jost and J. Ruland, Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications, Blood, vol.109, issue.7, pp.2700-2707, 2007.

L. Julian and M. Olson, Apoptotic membrane dynamics in health and disease, Cell Health and Cytoskeleton, vol.20157, pp.133-142, 2015.

K. Kang, K. Lee, M. Kim, and K. Choi, Terminus Potentiates Naphthoquinone Analog-induced Apoptosis, Journal of Biological Chemistry, vol.267, issue.27, pp.24638-24682, 2001.
DOI : 10.1073/pnas.94.19.10057

R. Kanwal and S. Gupta, Epigenetic modifications in cancer, Clinical Genetics, vol.8, issue.4, pp.303-314, 2012.
DOI : 10.4161/cc.8.6.7907

M. Karin and A. Lin, NF-??B at the crossroads of life and death, Nature Immunology, vol.18, issue.3, pp.221-228, 2002.
DOI : 10.1038/sj.onc.1202717

M. Kashani-sabet, L. Shaikh, . Miller, M. Nosrati, C. Ferreira et al., NF-??B in the Vascular Progression of Melanoma, Journal of Clinical Oncology, vol.22, issue.4, pp.617-640, 2004.
DOI : 10.1200/JCO.2004.06.047

M. Karin and A. Lin, NF-??B at the crossroads of life and death, Nature Immunology, vol.18, issue.3, pp.221-228, 2002.
DOI : 10.1038/sj.onc.1202717

G. Kasof, J. Prosser, D. Liu, M. Lorenzi, and B. Gomes, The RIP-like kinase, RIP3, induces apoptosis and NF-??B nuclear translocation and localizes to mitochondria, FEBS Letters, vol.2, issue.3, pp.285-91, 2000.
DOI : 10.1084/jem.189.2.381

I. Katayoun, A. Richmond, and A. Et-richmond, Role of nuclear factor-?B in melanoma, Cancer and Metastasis, vol.24, issue.2, pp.301-313, 2005.

A. Kater, M. Van-oers, and T. Kipps, Cellular immune therapy for chronic lymphocytic leukemia, Blood, vol.211, issue.4, pp.2811-2819, 2007.
DOI : 10.1111/j.0105-2896.2006.00379.x

S. Kaufmann, Imatinib spells BAD news for Bcr/abl-positive leukemias, Proceedings of the National Academy of Sciences, vol.86, issue.3, pp.14651-14653, 2006.
DOI : 10.1182/blood-2002-09-2780

H. Kim, F. Du, M. Fang, and X. Wang, Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1, Proceedings of the National Academy of Sciences, vol.57, issue.10, pp.17545-50, 2005.
DOI : 10.1126/science.1076807

H. Kim, I. Chang, J. Kim, K. Choi, and M. Lee, Caspase-Mediated p65 Cleavage Promotes TRAIL-Induced Apoptosis, Cancer Research, vol.65, issue.14, pp.6111-6120, 2005.
DOI : 10.1158/0008-5472.CAN-05-0472

J. Kim, S. Chu, J. Gramlich, Y. Pride, E. Babendreier et al., Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species, Blood, vol.105, issue.4, pp.1717-1740, 2005.
DOI : 10.1182/blood-2004-03-0849

Y. Kiraz, A. Adan, M. Yandim, and Y. Baran, Major apoptotic mechanisms and genes involved in apoptosis, Tumor Biology, vol.90, issue.2, pp.8471-86, 2016.
DOI : 10.1007/s00277-011-1212-5

D. Kirchner, J. Duyster, O. Ottmann, R. Schmid, L. Bergmann et al., Mechanisms of Bcr-Abl-mediated NF-??B/Rel activation, Experimental Hematology, vol.31, issue.6, pp.504-511, 2003.
DOI : 10.1016/S0301-472X(03)00069-9

L. Kleinberg, H. Dong, A. Holth, B. Risberg, C. Trope-' et al., Cleaved caspase-3 and nuclear factor-??B p65 are prognostic factors in metastatic serous ovarian carcinoma, Human Pathology, vol.40, issue.6, pp.795-806, 2009.
DOI : 10.1016/j.humpath.2008.10.019

H. Koh, Cutaneous Melanoma, New England Journal of Medicine, vol.325, issue.3, pp.171-82, 1991.
DOI : 10.1056/NEJM199107183250306

C. Krakstad and M. Chekenya, Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics, Molecular Cancer, vol.9, issue.1, p.135, 2010.
DOI : 10.1186/1476-4598-9-135

D. Krappmann and C. Scheidereit, A pervasive role of ubiquitin conjugation in activation and termination of I??B kinase pathways, EMBO reports, vol.128, issue.4, pp.321-327, 2005.
DOI : 10.1038/nature02273

G. Kroemer and B. Dallaporta, THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS, Annual Review of Physiology, vol.60, issue.1, pp.619-661, 1998.
DOI : 10.1146/annurev.physiol.60.1.619

M. Kuo, Z. Liu, Y. Wei, Y. Lin-lee, S. Tatebe et al., Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-??B signaling, Oncogene, vol.21, issue.13, pp.1945-54, 2002.
DOI : 10.1074/jbc.272.24.15174

M. Lamkanfi, N. Festjens, W. Declercq, T. Vanden-berghe, and P. Vandenabeele, Caspases in cell survival, proliferation and differentiation, Cell Death and Differentiation, vol.140, issue.1, pp.44-55, 2007.
DOI : 10.4049/jimmunol.170.12.6065

A. Lander, J. Kimble, H. Clevers, E. Fuchs, D. Montarras et al., What does the concept of the stem cell niche really mean today?, BMC Biology, vol.10, issue.1, pp.10-19, 2012.
DOI : 10.1186/1741-7007-10-19
URL : https://hal.archives-ouvertes.fr/pasteur-00677814

R. Langley, R. Carlisle, L. Ma, R. Specian, M. Gerritsen et al., Endothelial Expression of Vascular Cell Adhesion Molecule-1 Correlates with Metastatic Pattern in Spontaneous Melanoma, Microcirculation, vol.4, issue.5, pp.335-380, 2001.
DOI : 10.1007/978-94-009-8799-9_4

T. Leung, A. Hoffmann, and D. Baltimore, One Nucleotide in a ??B Site Can Determine Cofactor Specificity for NF-??B Dimers, Cell, vol.118, issue.4, pp.453-64, 2004.
DOI : 10.1016/j.cell.2004.08.007

B. Levkau, M. Scatena, C. Giachelli, R. Ross, and E. Raines, Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-??B loop, Nature Cell Biology, vol.5, issue.4, pp.227-260, 1999.
DOI : 10.1016/0735-0651(88)90023-4

H. Li, K. Chiappinelli, A. Guzzetta, H. Easwaran, R. Yen et al., Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers, Oncotarget, vol.5, issue.3, pp.587-98, 2014.
DOI : 10.18632/oncotarget.1782

J. Li, T. Mcquade, A. Siemer, J. Napetschnig, K. Moriwaki et al., The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis, Cell, vol.150, issue.2, pp.339-50, 2012.
DOI : 10.1016/j.cell.2012.06.019

M. Li, S. Feng, and M. Wu, Multiple roles for nuclear localization signal (NLS, aa 442???472) of receptor interacting protein 3 (RIP3), Biochemical and Biophysical Research Communications, vol.372, issue.4, pp.850-855, 2008.
DOI : 10.1016/j.bbrc.2008.05.144

S. Lim, C. Li, W. Xia, J. Cha, L. Chan et al., Deubiquitination and Stabilization of PD-L1 by CSN5, Cancer Cell, vol.30, issue.6, pp.925-939, 2016.
DOI : 10.1016/j.ccell.2016.10.010

Z. Lin, Q. Zhang, and W. Luo, Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions, European Journal of Pharmacology, vol.793, pp.76-81, 2016.
DOI : 10.1016/j.ejphar.2016.10.039

L. Ling, Z. Cao, and D. Goeddel, NF-??B-inducing kinase activates IKK-?? by phosphorylation of Ser-176, Proceedings of the National Academy of Sciences, vol.268, issue.23, pp.3792-3799, 1998.
DOI : 10.1016/S0092-8674(00)80351-7

S. Liptay, R. Schmid, E. Nabel, and G. Nabel, Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation., Molecular and Cellular Biology, vol.14, issue.12, pp.7695-703, 1994.
DOI : 10.1128/MCB.14.12.7695

M. Liu, T. Sakamaki, M. Casimiro, N. Willmarth, A. Quong et al., The Canonical NF-??B Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion, Cancer Research, vol.70, issue.24, pp.10464-73, 2010.
DOI : 10.1158/0008-5472.CAN-10-0732

J. Lo and D. Fisher, The melanoma revolution: From UV carcinogenesis to a new era in therapeutics, Science, vol.19, issue.1, pp.945-954, 2014.
DOI : 10.1016/j.jaad.2010.10.002

S. Lowe and C. Sherr, Tumor suppression by Ink4a???Arf: progress and puzzles, Current Opinion in Genetics & Development, vol.13, issue.1, pp.77-83, 2003.
DOI : 10.1016/S0959-437X(02)00013-8

S. Magister and J. Kos, Cystatins in Immune System, Journal of Cancer, vol.4, issue.1, pp.45-56, 2013.
DOI : 10.7150/jca.5044

J. Martinez-climent, L. Fontan, R. Gascoyne, R. Siebert, and F. Prosper, Lymphoma stem cells: enough evidence to support their existence?, Haematologica, vol.95, issue.2, pp.293-302, 2010.
DOI : 10.3324/haematol.2009.013318

M. Mancini, S. Petta, G. Martinelli, E. Barbieri, and M. A. Santucci, RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia, Journal of Cellular Biochemistry, vol.28, pp.320-328, 2010.
DOI : 10.1111/j.1365-2362.2007.01892.x

F. Martinon, N. Holler, C. Richard, and J. Tschopp, Activation of a pro-apoptotic amplification loop through inhibition of NF-??B-dependent survival signals by caspase-mediated inactivation of RIP, FEBS Letters, vol.274, issue.2-3, pp.134-140, 2000.
DOI : 10.1074/jbc.274.30.21155

H. Matsuoka, G. Sano, R. Hattori, H. Tomita, D. Yamamoto et al., One Injection of DsRed Followed by Bites from Transgenic Mosquitoes Producing DsRed in the Saliva Elicits a High Titer of Antibody in Mice, Tropical Medicine and Health, vol.40, issue.2, pp.47-53, 2012.
DOI : 10.1371/journal.pone.0017980

M. Mauzon, Les cellules souches hématopoïétiques : définition, origines et principales utilisations thérapeutiques Thèse de sciences biologie cellulaire, 2011.

S. Mcnulty, N. Tohidian, F. Meyskens, and . Jr, RelA, p50 and Inhibitor of kappa B alpha are Elevated in Human Metastatic Melanoma Cells and Respond Aberrantly to Ultraviolet Light B, Pigment Cell Research, vol.14, issue.6, pp.456-65, 2001.
DOI : 10.1034/j.1600-0749.2001.140606.x

A. Menzies and G. Long, Systemic treatment for BRAF-mutant melanoma: where do we go next?, The Lancet Oncology, vol.15, issue.9, pp.371-81, 2014.
DOI : 10.1016/S1470-2045(14)70072-5

A. Menzies and G. Long, Dabrafenib and Trametinib, Alone and in Combination for BRAF-Mutant Metastatic Melanoma, Clinical Cancer Research, vol.20, issue.8, pp.2035-2078, 2014.
DOI : 10.1158/1078-0432.CCR-13-2054

F. Mercurio, J. Didonato, C. Rosette, and M. Karin, Molecular Cloning and Characterization of a Novel Rel/NF-??B Family Member Displaying Structural and Functional Homology to NF-??B p50/p105, DNA and Cell Biology, vol.11, issue.7, pp.523-560, 1992.
DOI : 10.1089/dna.1992.11.523

F. Mercurio, J. Didonato, C. Rosette, and M. Karin, p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction., Genes & Development, vol.7, issue.4, pp.705-723, 1993.
DOI : 10.1101/gad.7.4.705

E. Meylan, F. Martinon, M. Thome, M. Gschwendt, and J. Tschopp, RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappaB and is processed during apoptosis, EMBO Reports, vol.3, issue.12, pp.1201-1209, 2002.
DOI : 10.1093/embo-reports/kvf236

E. Meylan, K. Burns, K. Hofmann, V. Blancheteau, F. Martinon et al., RIP1 is an essential mediator of Toll-like receptor 3???induced NF-??B activation, Nature Immunology, vol.8, issue.5, pp.503-510, 2004.
DOI : 10.1016/S0960-9822(07)00352-1

E. Meylan and J. Tschopp, The RIP kinases: crucial integrators of cellular stress, Trends in Biochemical Sciences, vol.30, issue.3, pp.151-160, 2005.
DOI : 10.1016/j.tibs.2005.01.003

O. Micheau, S. Lens, O. Gaide, K. Alevizopoulos, and J. Tschopp, NF-??B Signals Induce the Expression of c-FLIP, Molecular and Cellular Biology, vol.21, issue.16, pp.5299-305, 2001.
DOI : 10.1128/MCB.21.16.5299-5305.2001

S. Mitchell, J. Vargas, and A. Hoffmann, Signaling via the NF??B system, Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol.3, issue.3, pp.227-268, 2016.
DOI : 10.3389/fphys.2012.00170

T. Momoi, Caspases involved in ER stress-mediated cell death, Journal of Chemical Neuroanatomy, vol.28, issue.1-2, pp.101-106, 2004.
DOI : 10.1016/j.jchemneu.2004.05.008

W. Mooi, Diagnosis of thin melanoma., Journal of Clinical Pathology, vol.50, issue.3, pp.179-80, 1997.
DOI : 10.1136/jcp.50.3.179

K. Moore and I. Lemischka, Stem Cells and Their Niches, Science, vol.311, issue.5769, pp.1880-1885, 2006.
DOI : 10.1126/science.1110542

K. Moriwaki and F. Chan, Necrosis-dependent and independent signaling of the RIP kinases in inflammation, Cytokine & Growth Factor Reviews, vol.25, issue.2, pp.167-74, 2014.
DOI : 10.1016/j.cytogfr.2013.12.013

K. Moriwaki and F. Chan, RIP3: a molecular switch for necrosis and inflammation, Genes & Development, vol.27, issue.15, pp.1640-1649, 2013.
DOI : 10.1101/gad.223321.113

Y. Mosaad, Hematopoietic stem cells: An overview, Transfusion and Apheresis Science, vol.51, issue.3, pp.68-82, 2014.
DOI : 10.1016/j.transci.2014.10.016

R. Moschoi, V. Imbert, M. Nebout, J. Chiche, D. Mary et al., Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy, Blood, vol.33, issue.9, pp.253-64, 2016.
DOI : 10.1002/embj.201386030

S. Mowla, N. Perkins, and P. Jat, Friend or foe: emerging role of nuclear factor kappa-light-chainenhancer of activated B cells in cell senescence, Onco Targets Ther, vol.6, pp.1221-1230, 2013.

J. Müller and U. Siebenlist, Lymphotoxin ?? Receptor Induces Sequential Activation of Distinct NF-??B Factors via Separate Signaling Pathways, Journal of Biological Chemistry, vol.4, issue.14, pp.12006-12018, 2003.
DOI : 10.1016/S1074-7613(02)00423-5

E. Muñoz-couselo, J. García, J. Pérez-garcía, V. Cebrián, and J. Castán, Recent advances in the treatment of melanoma with BRAF and MEK inhibitors, Ann Transl Med, vol.3, issue.15, p.207, 2015.

B. Muz, P. De-la-puente, F. Azab, and A. Azab, The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy, Hypoxia, vol.3, pp.83-92, 2015.
DOI : 10.2147/HP.S93413

H. Nakano, M. Shindo, S. Sakon, S. Nishinaka, M. Mihara et al., Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1, Proc Natl Acad Sci, issue.7, pp.95-3537, 1998.

H. Nakshatri, P. Bhat-nakshatri, D. Martin, R. Goulet, . Jr et al., Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth., Molecular and Cellular Biology, vol.17, issue.7, pp.3629-3668, 1997.
DOI : 10.1128/MCB.17.7.3629

M. Naumann and C. Scheidereit, Activation of NF-kappa B in vivo is regulated by multiple phosphorylations, EMBO J, vol.13, pp.4597-607, 1994.

J. Neuzil, A. Schroder, P. Von-hundelshausen, A. Zernecke, T. Weber et al., Inhibition of Inflammatory Endothelial Responses by a Pathway Involving Caspase Activation and p65 Cleavage, Biochemistry, vol.40, issue.15, pp.4686-4692, 2001.
DOI : 10.1021/bi002498n

K. Newton, X. Sun, and V. Dixit, Kinase RIP3 Is Dispensable for Normal NF-??Bs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4, Molecular and Cellular Biology, vol.24, issue.4, pp.1464-1473, 2004.
DOI : 10.1128/MCB.24.4.1464-1469.2004
URL : http://mcb.asm.org/content/24/4/1464.full.pdf

N. Neznanov, K. Chumakov, and L. Neznanova,

, Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection, J Biol Chem, vol.280, issue.25, pp.24153-24161, 2005.

D. Novack, L. Yin, A. Hagen-stapleton, and R. Schreiber,

, The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis, J Exp Med, vol.198, issue.5, pp.771-81, 2003.

A. Nugues, H. Bouazzati, D. Hétuin, C. Berthon, A. Loyens et al., RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage, Cell Death & Disease, vol.15, issue.8, p.1384, 2014.
DOI : 10.1038/onc.2012.179

D. Ofengeim and J. Yuan, Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death, Nature Reviews Molecular Cell Biology, vol.3, issue.11, pp.727-763, 2013.
DOI : 10.1016/j.cmet.2006.01.011

P. Ostyn, Facteurs inflammatoires et contrôle de la quiescence/activation des cellules souches tumorales de mélanome, Thèse de Sciences, 2016.

H. Parker and J. Strefford, The mutational signature of chronic lymphocytic leukemia, Biochemical Journal, vol.473, issue.21, pp.3725-3740, 2016.
DOI : 10.1042/BCJ20160256

A. Parmiter and P. Nowell, Cytogenetics of Melanocytic Tumors, Journal of Investigative Dermatology, vol.100, issue.3, pp.254-258, 1993.
DOI : 10.1038/jid.1993.46

N. Pazdernik, D. Donner, M. Goebl, and M. Harrington, Mouse Receptor Interacting Protein 3 Does Not Contain a Caspase-Recruiting or a Death Domain but Induces Apoptosis and Activates NF-??B, Molecular and Cellular Biology, vol.19, issue.10
DOI : 10.1128/MCB.19.10.6500

, Mol Cell Biol, vol.19, issue.10, pp.6500-6508, 1999.

R. Pelayo, E. Dorantes-acosta, E. Vadillo, and E. Fuentes-panana, From HSC to B-Lymphoid Cells in Normal and Malignant Hematopoiesis, Advances in Hematopoietic Stem Cell Research InTech Chapter 13, 2012.
DOI : 10.5772/32213

J. Peng, J. Hamanishi, N. Matsumura, K. Abiko, K. Murat et al., Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-??B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer, Cancer Research, vol.75, issue.23, pp.5034-5079, 2015.
DOI : 10.1158/0008-5472.CAN-14-3098

N. Perkins, Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway, Oncogene, vol.25, issue.51, pp.6717-6747, 2006.
DOI : 10.1038/sj.onc.1209937

E. Pettijohn and S. Ma, Targeted Therapy in Chronic Lymphocytic Leukemia (CLL), Current Hematologic Malignancy Reports, vol.34, issue.15_suppl, pp.20-28, 2017.
DOI : 10.1182/blood-2016-03-707133

J. Pomerantz and D. Baltimore, Two Pathways to NF-??B, Molecular Cell, vol.10, issue.4, pp.693-698, 2002.
DOI : 10.1016/S1097-2765(02)00697-4

J. Prada-arismendy, J. Arroyave, and S. Röthlisberger, Molecular biomarkers in acute myeloid leukemia, Blood Reviews, vol.31, issue.1, pp.63-76, 2017.
DOI : 10.1016/j.blre.2016.08.005

J. Pradère, C. Hernandez, C. Koppe, R. Friedman, T. Luedde et al., Negative regulation of NF-??B p65 activity by serine 536 phosphorylation, Science Signaling, vol.316, issue.442, p.85, 2016.
DOI : 10.1016/j.ccr.2012.02.007

E. Quintana, M. Shackleton, M. Sabel, D. Fullen, T. Johnson et al., Efficient tumour formation by single human melanoma cells, Nature, vol.24, issue.7222, pp.593-601, 2008.
DOI : 10.4049/jimmunol.174.10.6477

V. Quivy and C. Van-lint, Regulation at multiple levels of NF-??B-mediated transactivation by protein acetylation, Biochemical Pharmacology, vol.68, issue.6, pp.1221-1230, 2004.
DOI : 10.1016/j.bcp.2004.05.039

R. Ravi, A. Bedi, E. Fuchs, and A. Bedi, CD95 (Fas)-induced caspase-mediated proteolysis of NFkappaB, Cancer Res, vol.58, issue.5, pp.882-888, 1998.

R. Ravi, G. Bedi, L. Engstrom, Q. Zeng, B. Mookerjee et al., Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-??B, Nature Cell Biology, vol.58, issue.4, pp.409-425, 2001.
DOI : 10.1084/jem.189.6.999

M. Rebsamen, L. Heinz, E. Meylan, M. Michallet, K. Schroder et al., DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-??B, EMBO reports, vol.181, issue.8, pp.916-938, 2009.
DOI : 10.1073/pnas.0801295105

T. Regad, Molecular and cellular pathogenesis of melanoma initiation and progression, Cellular and Molecular Life Sciences, vol.364, issue.26, pp.4055-65, 2013.
DOI : 10.1056/NEJMoa1210093

S. Reshkin, M. Greco, and R. Cardone, Role of pHi, and proton transporters in oncogene-driven neoplastic transformation, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.133, issue.29, 2016.
DOI : 10.1021/ja201930p

J. Reuther, G. Reuther, D. Cortez, A. Pendergast, A. Baldwin et al., A requirement for NF-kappa B activation in Bcr-Abl-mediated??transformation, Genes & Development, vol.12, issue.7, pp.968-81, 1998.
DOI : 10.1101/gad.12.7.968

T. Reya, S. Morrison, M. Clarke, and I. Weissman, Stem cells, cancer and cancer stem cells, Nature, vol.66, issue.6859, pp.105-116, 2001.
DOI : 10.1016/0092-8674(91)90111-B

A. Ricca, A. Biroccio, D. Trisciuoglio, M. Cippitelli, and G. Zupi, relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells, British Journal of Cancer, vol.85, issue.12, pp.1914-1935, 2001.
DOI : 10.1054/bjoc.2001.2174

N. Rice, M. Mackichan, and A. Israël, The precursor of NF-??B p50 has I??B-like functions, Cell, vol.71, issue.2, pp.243-53, 1992.
DOI : 10.1016/0092-8674(92)90353-E

E. Rofstad and E. Halsør, Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts, Cancer Res, vol.60, issue.17, pp.4932-4940, 2000.

E. Routier, C. Robert, and C. Mateus, Immunotherapies and melanoma, Bulletin Cancer, vol.101, pp.13-24, 2014.

F. Santos, H. Kantarjian, A. Quintas-cardama, and J. Cortes, Evolution of Therapies for Chronic Myelogenous Leukemia, The Cancer Journal, vol.17, issue.6, pp.465-76, 2011.
DOI : 10.1097/PPO.0b013e31823dec8d

D. Sarbassov, S. Ali, and D. Sabatini, Growing roles for the mTOR pathway, Current Opinion in Cell Biology, vol.17, issue.6, pp.596-603, 2005.
DOI : 10.1016/j.ceb.2005.09.009

A. Saudemont and B. Quesnel, In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis, Blood, vol.104, issue.7, pp.2124-2157, 2004.
DOI : 10.1182/blood-2004-01-0064

A. Saudemont, N. Jouy, D. Hetuin, and B. Quesnel, NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells, Blood, vol.105, issue.6, pp.2428-2463, 2005.
DOI : 10.1182/blood-2004-09-3458

N. Saudy, I. Fawzy, E. Azmy, E. Goda, A. Eneen et al., BMI1 gene expression in myeloid leukemias and its impact on prognosis, Blood Cells, Molecules, and Diseases, vol.53, issue.4, pp.194-202, 2014.
DOI : 10.1016/j.bcmd.2014.07.002

R. Sen and D. Baltimore, Inducibility of ?? immunoglobulin enhancer-binding protein NF-??B by a posttranslational mechanism, Cell, vol.47, issue.6, pp.921-929, 1986.
DOI : 10.1016/0092-8674(86)90807-X

E. Sertaridou, V. Papaioannou, and G. Kolios, Pneumatikos, I. Gut failure in critical care: old school versus new school, Ann Gastroenterol, vol.28, issue.3, pp.309-322, 2015.

S. Shalini, L. Dorstyn, S. Dawar, and S. Kumar, Old, new and emerging functions of caspases, Cell Death & Differentiation, vol.4, issue.4, pp.526-565, 2015.
DOI : 10.1016/j.cell.2010.03.053

R. Shattuck-brandt and A. Richmond, Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells, Cancer Res, vol.57, issue.14, pp.3032-3041, 1997.

J. Shay and W. Wright, Role of telomeres and telomerase in cancer, Seminars in Cancer Biology, vol.21, issue.6, pp.349-353, 2011.
DOI : 10.1016/j.semcancer.2011.10.001

R. Shen and W. Hahn, Emerging roles for the non-canonical IKKs in cancer, Oncogene, vol.18, issue.6, pp.631-672, 2011.
DOI : 10.1074/jbc.M801451200

D. Shenenberger, Cutaneous malignant melanoma: a primary care perspective, Am. Fam. Physician, vol.85, issue.2, pp.161-169, 2012.

S. Shigdar, Y. Li, S. Bhattacharya, M. O-'connor, C. Pu et al., Inflammation and cancer stem cells, Cancer Letters, vol.345, issue.2, pp.271-279, 2014.
DOI : 10.1016/j.canlet.2013.07.031

I. Shih and M. Herlyn, Autocrine and paracrine roles for growth factors in melanoma, In Vivo, vol.8, issue.1, pp.113-136, 1994.

V. Shih, R. Tsui, A. Caldwell, and A. Hoffmann, A single NF??B system for both canonical and non-canonical signaling, Cell Research, vol.14, issue.1, pp.86-102, 2011.
DOI : 10.1016/0092-8674(95)90415-8

N. Short and F. Ravandi, Acute Myeloid Leukemia: Past, Present, and Prospects for the Future, Clinical Lymphoma Myeloma and Leukemia, vol.16, issue.S1, pp.25-29, 2016.
DOI : 10.1016/j.clml.2016.02.007

V. Sondak, M. Ross, and L. Schuchter, Early stage (I, II, III) melanoma, Current Treatment Options in Oncology, vol.23, issue.3, pp.183-91, 2001.
DOI : 10.1016/0360-3016(94)90351-4

M. Sosa, P. Bragado, and J. Aguirre-ghiso, Mechanisms of disseminated cancer cell dormancy: an awakening field, Nature Reviews Cancer, vol.12, issue.9, pp.611-633, 2014.
DOI : 10.1091/mbc.12.4.863

M. Sovak, R. Bellas, D. Kim, and G. Zanieski,

, Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer, J Clinic Invest, vol.100, issue.12, pp.2952-60, 1997.

F. Spagnolo, P. Ghiorzo, and P. Queirolo, Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma, Oncotarget, vol.5, issue.21, pp.10206-10227, 2014.
DOI : 10.18632/oncotarget.2602

L. Steelman, S. Pohnert, J. Shelton, R. Franklin, F. Bertrand et al., JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis, Leukemia, vol.23, issue.2, pp.189-218, 2004.
DOI : 10.1016/S0165-6147(00)01865-4
URL : http://www.nature.com/leu/journal/v18/n2/pdf/2403241a.pdf

D. Stirewalt, S. Meshinchi, and J. Radich, Molecular targets in acute myelogenous leukemia, Blood Reviews, vol.17, issue.1, pp.15-23, 2003.
DOI : 10.1016/S0268-960X(02)00057-7

H. Su and M. Lenardo, Genetic Defects of Apoptosis and Primary Immunodeficiency, Immunology and Allergy Clinics of North America, vol.28, issue.2, pp.329-51, 2008.
DOI : 10.1016/j.iac.2008.01.002
URL : http://europepmc.org/articles/pmc2671802?pdf=render

L. Sun, H. Wang, Z. Wang, S. He, S. Chen et al., Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase, Cell, vol.148, issue.1-2, pp.213-240, 2012.
DOI : 10.1016/j.cell.2011.11.031
URL : https://doi.org/10.1016/j.cell.2011.11.031

W. Sun, L. Schuchter, and . Metastasic-melanoma, Metastatic melanoma, Current Treatment Options in Oncology, vol.115, issue.3, pp.193-202, 2001.
DOI : 10.1007/s11864-001-0033-5

X. Sun, J. Lee, T. Navas, D. Baldwin, T. Stewart et al., RIP3, a Novel Apoptosis-inducing Kinase, Journal of Biological Chemistry, vol.200, issue.24, pp.16871-16876, 1999.
DOI : 10.1038/383443a0
URL : http://www.jbc.org/content/274/24/16871.full.pdf

X. Sun, J. Yin, M. Starovasnik, W. Fairbrother, and V. Dixit, Identification of a Novel Homotypic Interaction Motif Required for the Phosphorylation of Receptor-interacting Protein (RIP) by RIP3, Journal of Biological Chemistry, vol.19, issue.11, pp.9505-9516, 2002.
DOI : 10.1016/S1074-7613(00)80183-1

U. Testa, Leukemia stem cells, Annals of Hematology, vol.464, issue.pt5, pp.245-71, 2011.
DOI : 10.1038/nature08851

E. Tucker, K. O-'donnell, M. Fuchsberger, A. Hilton, D. Metcalf et al., A Novel Mutation in the Nfkb2 Gene Generates an NF-??B2 "Super Repressor", The Journal of Immunology, vol.179, issue.11, pp.7514-7536, 2007.
DOI : 10.4049/jimmunol.179.11.7514
URL : http://www.jimmunol.org/content/jimmunol/179/11/7514.full.pdf

A. G. Turhan, Leucémie myéloïde chronique : actualités biologiques et thérapeutiques, Bull Cancer, vol.92, issue.1, pp.75-82, 2004.

Y. Ueda and A. Richmond, NF-kappaB activation in melanoma, Pigment Cell Research, vol.157, issue.2, pp.112-136, 2006.
DOI : 10.1038/sj.bjc.6602598
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0749.2006.00304.x/pdf

J. Um, C. Kang, B. Lee, D. Kim, B. Chung et al., Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance, Oncogene, vol.20, issue.42, pp.6048-56, 2001.
DOI : 10.1074/jbc.272.24.15174
URL : http://www.nature.com/onc/journal/v20/n42/pdf/1204732a.pdf

A. Van-de-stolpe, E. Caldenhoven, B. Stade, L. Koenderman, J. Raaijmakers et al., 12-O-tetradecanoylphorbol-13-acetate-and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter, J Biol Chem, vol.269, issue.8, pp.6185-92, 1994.

P. Vandenabeele, W. Declercq, and F. Van-herreweghe, Vanden Berghe, T. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis, Sci Signal, vol.3, issue.115, p.4, 2010.

E. Vakana, A. Sassano, and L. C. Platanias, Induction of autophagy by dual mTORC1-mTORC2 inhibition in BCR-ABL-expressing leukemic cells, Autophagy, vol.6, issue.7, pp.966-967, 2010.
DOI : 10.4161/auto.6.7.13067
URL : http://www.tandfonline.com/doi/pdf/10.4161/auto.6.7.13067?needAccess=true

R. Vereecque, G. Buffenoir, R. Gonzalez, C. Preudhomme, P. Fenaux et al., A new murine aggressive leukemic model, Leukemia Research, vol.23, issue.4, pp.415-421, 1999.

R. Vereecque, A. Saudemont, and B. Quesnel, Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells, Leukemia, vol.102, issue.7, pp.1223-1253, 2004.
DOI : 10.1182/blood-2003-01-0150
URL : http://www.nature.com/leu/journal/v18/n7/pdf/2403391a.pdf

L. Vermeulen, G. De-wilde, S. Notebaert, W. Vanden-berghe, and G. Haegeman, Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit, Biochem Pharmacol, vol.64, pp.5-6, 2002.

P. Viatour, M. Merville, V. Bours, and A. Chariot, Phosphorylation of NF-??B and I??B proteins: implications in cancer and inflammation, Trends in Biochemical Sciences, vol.30, issue.1, pp.43-52, 2005.
DOI : 10.1016/j.tibs.2004.11.009

E. Viennois, F. Chen, and D. Merlin, NF-?B pathway in colitis-associated cancers, Transl Gastrointest Cancer, vol.2, issue.1, pp.21-29, 2013.

D. Vucic, H. Stennicke, M. Pisabarro, G. Salvesen, and V. Dixit, ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas, Current Biology, vol.10, issue.21, pp.1359-66, 2000.
DOI : 10.1016/S0960-9822(00)00781-8

C. Wang, M. Mayo, R. Korneluk, D. Goeddel, A. Baldwin et al., NF-B Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation, Science, vol.281, issue.5383, pp.1680-1683, 1998.
DOI : 10.1126/science.281.5383.1680

C. Wang, J. Cusack, . Jr, R. Liu, and . Baldwin, Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-??B, Nature Medicine, vol.3, issue.4, pp.412-419, 1999.
DOI : 10.1038/nm0697-606

D. Wang, W. Yang, J. Du, M. Devalaraja, P. Liang et al., MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression, Oncogene, vol.19, issue.40, pp.4647-59, 2000.
DOI : 10.1074/jbc.274.16.11328

T. Wang, S. Shigdar, M. Gantier, Y. Hou, L. Wang et al., Cancer stem cell targeted therapy: progress amid controversies, Oncotarget, vol.6, issue.42, pp.44191-206, 2015.
DOI : 10.18632/oncotarget.6176

W. Wang, J. Abbruzzese, D. Evans, L. Larry, K. Cleary et al., The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarvinoma cells, Clinic Cancer Research, vol.5, issue.1, pp.119-146, 1999.

S. Werner, D. Barken, and A. Hoffmann, Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity, Science, vol.309, issue.5742, pp.1857-61, 2005.
DOI : 10.1126/science.1113319

E. Wier, K. Fu, A. Hodgson, X. Sun, and F. Wan, Caspase-3 cleaved p65 fragment dampens NF-??B-mediated anti-apoptotic transcription by interfering with the p65/RPS3 interaction, FEBS Letters, vol.5, issue.23, pp.3581-3588, 2015.
DOI : 10.1038/srep09015

G. Xiao, E. Harhaj, and S. Sun, NF-??B-Inducing Kinase Regulates the Processing of NF-??B2 p100, Molecular Cell, vol.7, issue.2, pp.401-410, 2001.
DOI : 10.1016/S1097-2765(01)00187-3

J. Yang and A. Richmond, Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells, Cancer Res, vol.61, issue.12, pp.4901-4910, 2001.

Y. Yang, J. Ma, Y. Chen, and M. Wu, Nucleocytoplasmic Shuttling of Receptor-interacting Protein 3 (RIP3), Journal of Biological Chemistry, vol.19, issue.37, pp.38820-38829, 2004.
DOI : 10.1101/gad.13.19.2514

A. Yaron, A. Hatzubai, M. Davis, I. Lavon, S. Amit et al., Identification of the receptor component of the I??B?????ubiquitin ligase, Nature, vol.270, issue.6711, pp.590-594, 1998.
DOI : 10.1074/jbc.270.51.30408

D. Yeh, L. Huang, Y. Chen, C. Huang, and T. Chuang, Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling, Journal of Immunology Research, vol.8, issue.6, p.4368101, 2016.
DOI : 10.1016/S1074-7613(02)00449-1

H. Yu, M. Wu, B. Wen, N. Sun, D. Xiang et al., Antagonist effect of interleukin 1 receptor on normal thymopoiesis and thymus toxicity of 5- azacytidine in mouse, American J Transl Res, vol.8, issue.2, pp.1237-1282, 2016.

P. Yu, B. Huang, M. Shen, J. Quast, E. Chan et al., Identification of RIP3, a RIP-like kinase that activates apoptosis and NF??B, Current Biology, vol.9, issue.10, pp.539-581, 1999.
DOI : 10.1016/S0960-9822(99)80239-5

D. Zhang, J. Lin, and J. Han, Receptor-interacting protein (RIP) kinase family, Cellular & Molecular Immunology, vol.171, issue.4, pp.243-252, 2010.
DOI : 10.1111/j.1471-4159.2009.06024.x

D. Zhang, J. Shao, J. Lin, N. Zhang, B. Lu et al., RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis, Science, vol.1, issue.2, pp.332-338, 2009.
DOI : 10.1038/nchembio711

Q. Zhang, M. Lenardo, and D. Baltimore, 30 Years of NF-??B: A Blossoming of Relevance to Human Pathobiology, Cell, vol.168, issue.1-2, pp.37-57, 2017.
DOI : 10.1016/j.cell.2016.12.012

J. Zhao, S. Jitkaew, Z. Cai, S. Choksi, Q. Li et al., Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis, Proceedings of the National Academy of Sciences, vol.148, issue.5, pp.5322-5329, 2012.
DOI : 10.1016/j.molcel.2006.01.018

H. Zhou and R. Xu, Leukemia stem cells: the root of chronic myeloid leukemia, Protein & Cell, vol.5, issue.6, pp.403-415, 2015.
DOI : 10.1002/emmm.201201760

G. Zhou and M. Kuo, Expression by Insulin in Rat Hepatoma Cells, Journal of Biological Chemistry, vol.13, issue.24, pp.15174-83, 1997.
DOI : 10.3109/07357909509024911

J. Zhou, Y. Ching, . Chng, and . Wj, Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target, Oncotarget, vol.6, issue.8, pp.5490-500, 2015.
DOI : 10.18632/oncotarget.3545

W. Zhou and J. Yuan, Necroptosis in health and diseases, Seminars in Cell & Developmental Biology, vol.35, pp.14-23, 2014.
DOI : 10.1016/j.semcdb.2014.07.013